Cargando…

N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope

Fibroblast growth factor receptor 1 (FGFR1) is a heavily N-glycosylated cell surface receptor tyrosine kinase that transmits signals across the plasma membrane, in response to fibroblast growth factors (FGFs). Balanced FGF/FGFR1 signaling is crucial for the development and homeostasis of the human b...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregorczyk, Paulina, Porębska, Natalia, Żukowska, Dominika, Chorążewska, Aleksandra, Gędaj, Aleksandra, Malinowska, Agata, Otlewski, Jacek, Zakrzewska, Małgorzata, Opaliński, Łukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362638/
https://www.ncbi.nlm.nih.gov/pubmed/37480072
http://dx.doi.org/10.1186/s12964-023-01203-3
_version_ 1785076469306753024
author Gregorczyk, Paulina
Porębska, Natalia
Żukowska, Dominika
Chorążewska, Aleksandra
Gędaj, Aleksandra
Malinowska, Agata
Otlewski, Jacek
Zakrzewska, Małgorzata
Opaliński, Łukasz
author_facet Gregorczyk, Paulina
Porębska, Natalia
Żukowska, Dominika
Chorążewska, Aleksandra
Gędaj, Aleksandra
Malinowska, Agata
Otlewski, Jacek
Zakrzewska, Małgorzata
Opaliński, Łukasz
author_sort Gregorczyk, Paulina
collection PubMed
description Fibroblast growth factor receptor 1 (FGFR1) is a heavily N-glycosylated cell surface receptor tyrosine kinase that transmits signals across the plasma membrane, in response to fibroblast growth factors (FGFs). Balanced FGF/FGFR1 signaling is crucial for the development and homeostasis of the human body, and aberrant FGFR1 is frequently observed in various cancers. In addition to its predominant localization to the plasma membrane, FGFR1 has also been detected inside cells, mainly in the nuclear lumen, where it modulates gene expression. However, the exact mechanism of FGFR1 nuclear transport is still unknown. In this study, we generated a glycosylation-free mutant of FGFR1, FGFR1.GF, and demonstrated that it is localized primarily to the nuclear envelope. We show that reintroducing N-glycans into the D3 domain cannot redirect FGFR1 to the plasma membrane or exclude the receptor from the nuclear envelope. Reestablishment of D2 domain N-glycans largely inhibits FGFR1 accumulation in the nuclear envelope, but the receptor continues to accumulate inside the cell, mainly in the ER. Only the simultaneous presence of N-glycans of the D2 and D3 domains of FGFR1 promotes efficient transport of FGFR1 to the plasma membrane. We demonstrate that while disturbed FGFR1 folding results in partial FGFR1 accumulation in the ER, impaired FGFR1 secretion drives FGFR1 trafficking to the nuclear envelope. Intracellular FGFR1.GF displays a high level of autoactivation, suggesting the presence of nuclear FGFR1 signaling, which is independent of FGF. Using mass spectrometry and proximity ligation assay, we identified novel binding partners of the nuclear envelope-localized FGFR1, providing insights into its cellular functions. Collectively, our data define N-glycosylation of FGFR1 as an important regulator of FGFR1 kinase activity and, most importantly, as a switchable signal for FGFR1 trafficking between the nuclear envelope and plasma membrane, which, due to spatial restrictions, shapes FGFR1 interactome and cellular function. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-023-01203-3.
format Online
Article
Text
id pubmed-10362638
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103626382023-07-23 N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope Gregorczyk, Paulina Porębska, Natalia Żukowska, Dominika Chorążewska, Aleksandra Gędaj, Aleksandra Malinowska, Agata Otlewski, Jacek Zakrzewska, Małgorzata Opaliński, Łukasz Cell Commun Signal Brief Report Fibroblast growth factor receptor 1 (FGFR1) is a heavily N-glycosylated cell surface receptor tyrosine kinase that transmits signals across the plasma membrane, in response to fibroblast growth factors (FGFs). Balanced FGF/FGFR1 signaling is crucial for the development and homeostasis of the human body, and aberrant FGFR1 is frequently observed in various cancers. In addition to its predominant localization to the plasma membrane, FGFR1 has also been detected inside cells, mainly in the nuclear lumen, where it modulates gene expression. However, the exact mechanism of FGFR1 nuclear transport is still unknown. In this study, we generated a glycosylation-free mutant of FGFR1, FGFR1.GF, and demonstrated that it is localized primarily to the nuclear envelope. We show that reintroducing N-glycans into the D3 domain cannot redirect FGFR1 to the plasma membrane or exclude the receptor from the nuclear envelope. Reestablishment of D2 domain N-glycans largely inhibits FGFR1 accumulation in the nuclear envelope, but the receptor continues to accumulate inside the cell, mainly in the ER. Only the simultaneous presence of N-glycans of the D2 and D3 domains of FGFR1 promotes efficient transport of FGFR1 to the plasma membrane. We demonstrate that while disturbed FGFR1 folding results in partial FGFR1 accumulation in the ER, impaired FGFR1 secretion drives FGFR1 trafficking to the nuclear envelope. Intracellular FGFR1.GF displays a high level of autoactivation, suggesting the presence of nuclear FGFR1 signaling, which is independent of FGF. Using mass spectrometry and proximity ligation assay, we identified novel binding partners of the nuclear envelope-localized FGFR1, providing insights into its cellular functions. Collectively, our data define N-glycosylation of FGFR1 as an important regulator of FGFR1 kinase activity and, most importantly, as a switchable signal for FGFR1 trafficking between the nuclear envelope and plasma membrane, which, due to spatial restrictions, shapes FGFR1 interactome and cellular function. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-023-01203-3. BioMed Central 2023-07-21 /pmc/articles/PMC10362638/ /pubmed/37480072 http://dx.doi.org/10.1186/s12964-023-01203-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Brief Report
Gregorczyk, Paulina
Porębska, Natalia
Żukowska, Dominika
Chorążewska, Aleksandra
Gędaj, Aleksandra
Malinowska, Agata
Otlewski, Jacek
Zakrzewska, Małgorzata
Opaliński, Łukasz
N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
title N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
title_full N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
title_fullStr N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
title_full_unstemmed N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
title_short N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
title_sort n-glycosylation acts as a switch for fgfr1 trafficking between the plasma membrane and nuclear envelope
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362638/
https://www.ncbi.nlm.nih.gov/pubmed/37480072
http://dx.doi.org/10.1186/s12964-023-01203-3
work_keys_str_mv AT gregorczykpaulina nglycosylationactsasaswitchforfgfr1traffickingbetweentheplasmamembraneandnuclearenvelope
AT porebskanatalia nglycosylationactsasaswitchforfgfr1traffickingbetweentheplasmamembraneandnuclearenvelope
AT zukowskadominika nglycosylationactsasaswitchforfgfr1traffickingbetweentheplasmamembraneandnuclearenvelope
AT chorazewskaaleksandra nglycosylationactsasaswitchforfgfr1traffickingbetweentheplasmamembraneandnuclearenvelope
AT gedajaleksandra nglycosylationactsasaswitchforfgfr1traffickingbetweentheplasmamembraneandnuclearenvelope
AT malinowskaagata nglycosylationactsasaswitchforfgfr1traffickingbetweentheplasmamembraneandnuclearenvelope
AT otlewskijacek nglycosylationactsasaswitchforfgfr1traffickingbetweentheplasmamembraneandnuclearenvelope
AT zakrzewskamałgorzata nglycosylationactsasaswitchforfgfr1traffickingbetweentheplasmamembraneandnuclearenvelope
AT opalinskiłukasz nglycosylationactsasaswitchforfgfr1traffickingbetweentheplasmamembraneandnuclearenvelope